Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-21

FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved a supplemental application for Amneal Pharmaceuticals NY LLC for CARBIDOPA AND LEVODOPA (carbidopa-levodopa).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)